PUBLISHER: 360iResearch | PRODUCT CODE: 1466640
PUBLISHER: 360iResearch | PRODUCT CODE: 1466640
[196 Pages Report] The Antimicrobial Resistance Surveillance Market size was estimated at USD 5.60 billion in 2023 and expected to reach USD 5.96 billion in 2024, at a CAGR 6.49% to reach USD 8.71 billion by 2030.
The antimicrobial resistance surveillance market encompasses products to monitor, analyze, and control the spread of microorganisms that develop resistance to antibiotics, antivirals, antifungals, and other antimicrobial agents. The primary application of antimicrobial resistance surveillance is to provide information on the prevalence of resistant pathogens in various settings such as hospitals, community health centers, food production facilities, animal husbandry operations, water treatment plants, and environmental samples. The increasing prevalence of multidrug-resistant organisms worldwide necessitates constant monitoring to adapt existing treatments appropriately. Advances in molecular diagnostics techniques enable early detection and identification of antibiotic-resistant strains. Addtionally, growing awareness about antibiotic stewardship programs among healthcare professionals encourages prudent prescribing practices. Despite the growth prospects, several challenges hinder the antimicrobial resistance surveillance market progress. Inadequate infrastructure and funding in low and middle-income countries result in limited surveillance capabilities. Variability in laboratory methodologies employed worldwide hampers comparability of results across regions. However, the emergence of point-of-care testing devices expedites diagnosis and enables personalized treatment decisions. Harnessing genomic sequencing technologies allows for accurate tracking of resistance mechanisms and transmission dynamics at a population level. Along with these, to sustain business growth and contribute to global health security, stakeholders should focus on key areas like refining diagnostic tools for faster detection, exploring unconventional treatment approaches, utilizing artificial intelligence for predictive modeling.
KEY MARKET STATISTICS | |
---|---|
Base Year [2023] | USD 5.60 billion |
Estimated Year [2024] | USD 5.96 billion |
Forecast Year [2030] | USD 8.71 billion |
CAGR (%) | 6.49% |
Component: Significant role of diagnostic kits in offering rapid detection of specific resistance markers at relatively lower costs
The antimicrobial resistance (AMR) surveillance market comprises various components that help identify and manage drug-resistant pathogens. Diagnostic kits are essential for accurate and rapid detection of antimicrobial resistance in pathogens, enabling timely intervention with appropriate antibiotic therapy. These kits employ various techniques such as polymerase chain reaction (PCR), enzyme-linked immunosorbent assays (ELISA), and next-generation sequencing (NGS) to identify resistant genes in microorganisms. Diagnostic systems encompass laboratory-based instruments that facilitate high-throughput screening and advanced data analysis for AMR detection. AMR surveillance services include contract research organizations (CROs) and laboratories that provide accelerated susceptibility testing, whole-genome sequencing, and bioinformatics analysis. These services enable healthcare providers to access cutting-edge technology and expertise for detecting resistant pathogens without investing in expensive equipment or specialists. Data management software plays a crucial role in compiling, analyzing, and interpreting the vast amount of information generated during AMR surveillance.
End-User: Increasing incidence of hospital-acquired infections developed necessities for next generation antimicrobial resistance (AMR) surveillance
In the fight against antimicrobial resistance (AMR), hospitals and research & academic institutes play critical roles, necessitating tailored surveillance systems to address their distinct needs. Hospitals prioritize rapid diagnostic solutions that guide clinicians in providing appropriate antibiotic treatments and preventing the spread of resistant infections. Research & academic institutes focus on understanding antimicrobial resistance mechanisms, developing novel therapeutic approaches, and promoting responsible antibiotic use among healthcare professionals.
Regional Insights
Antimicrobial resistance (AMR) has emerged as a significant public health threat across the Americas and Europe. Continuous surveillance of AMR is crucial in understanding the growing impact on healthcare systems, guiding policy decisions, and implementing effective strategies to mitigate the risks associated with resistant infections. The major driving factors behind increased AMR levels in the Americas and Europe include the overuse and misuse of antimicrobials in human medicine, veterinary practice, agriculture, and food production sectors. In developed countries across the Americas and Europe, stringent regulatory frameworks govern the actions of manufacturers and providers of antimicrobial products. The potential associated with emerging countries in addressing AMR is immense due to factors such as rapid economic growth, increasing healthcare expenditure, and favorable government policies. Emerging economies like India, China, and Brazil are investing heavily in R&D for antimicrobial resistance surveillance and promoting public-private partnerships to address the issue. Governments provide financial support for research and development (R&D) efforts to incentivize innovation in addressing antimicrobial resistance. For instance, in August 2023, the UK government made a significant investment of £210 million to enhance global surveillance of drug-resistant bacteria, a critical aspect of Antimicrobial Resistance (AMR) surveillance. However, initiatives focusing on surveillance systems enhancement, regulatory oversight improvements, investment in research, and development of new treatments are crucial to combating this threat effectively.
FPNV Positioning Matrix
The FPNV Positioning Matrix is pivotal in evaluating the Antimicrobial Resistance Surveillance Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Antimicrobial Resistance Surveillance Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Key Company Profiles
The report delves into recent significant developments in the Antimicrobial Resistance Surveillance Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Accelerate Diagnostics, Inc., Becton, Dickinson and Company, bioMerieux SA, Cepheid, F. Hoffmann-La Roche Ltd, GlaxoSmithKline PLC, Johnson & Johnson Services Inc., Liofilchem S.r.l., Lumed, Luminex Corporation, Merck & Co., Inc., Novo Holdings A/S, OpGen, Inc., Pfizer Inc., QIAGEN GmbH, Sanofi S.A., Thermo Fisher Scientific Inc., Venatorx Pharmaceuticals, Inc., Viatris Inc., Vivli Inc., and Wolters Kluwer N.V..
Market Segmentation & Coverage
1. Market Penetration: It presents comprehensive information on the market provided by key players.
2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.
1. What is the market size and forecast of the Antimicrobial Resistance Surveillance Market?
2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Antimicrobial Resistance Surveillance Market?
3. What are the technology trends and regulatory frameworks in the Antimicrobial Resistance Surveillance Market?
4. What is the market share of the leading vendors in the Antimicrobial Resistance Surveillance Market?
5. Which modes and strategic moves are suitable for entering the Antimicrobial Resistance Surveillance Market?